Bullish
$CRMD Folks, Remember the FDA doesn’t grant rolling review and LPAD status for meds it doesn’t plan on approving! We were approved by FDA for both! We are on track for approval in Q3/Q4! Your Buying for less than all the board members!
  • 13
  • 2